www.wsj.com Trump’s Plan to Lower Drug Prices in U.S. Is Leading to Fewer New Drugs in Europe An analysis shows that 27% fewer drugs launched in Europe since President Trump’s international drug-pricing policy began. 
www.wsj.com RFK Jr. Allows Unapproved Peptides on the Market Experts have warned there isn’t sufficient evidence showing peptides are safe or effective. 
www.wsj.com Moderna’s Cancer Vaccine Success Doesn’t Live Up to Early Hype The company’s stock dropped after details of a study raised questions about how widely the treatment would be used. 
www.wsj.com Big Pharma Is Pouring Billions Into a New Class of ‘Protein Degrader’ Drugs New medications are showing promise in going after a certain kind of hard-to-target protein in diseased cells. 
www.statnews.com Helen Branswell, whose reporting on infectious diseases and public health drew acclaim, dies at 69 Helen Branswell, STAT's infectious disease reporter who earned the respect of experts and public health officials with her accessible, prescient dispatches, has died at age 69. 